Regulator finds key disclosure and fraud allegations unsubstantiated after examining transactions spanning 2010, 2015 and 2020

The Securities and Exchange Board of India (Sebi) has disposed of proceedings against Max Financial Services, Max Life Insurance and entities associated with the Axis Group in a case involving an alleged ₹3,911.95 crore loss to Max Financial shareholders.

In its final order, the market regulator said the allegations relating to inadequate disclosures and an alleged fraudulent scheme could not ultimately be established. Proceedings against seven individuals, including Max Group founder and Chairman Analjit Singh, have also been dropped.

The case followed an extensive examination of transactions between Max and Axis entities covering the period from 2009-10 to 2021-22.

Sebi examined three sets of transactions

The regulator's investigation focused primarily on arrangements entered into in 2010, 2015 and 2020.

The 2010 arrangement involved the issuance of Max Life shares to Axis Bank at par, followed by their acquisition in multiple tranches at progressively higher prices.

The 2015 arrangement involved Max Financial, Mitsui Sumitomo Insurance Company and Axis Bank in connection with the transfer of nearly 4.99 per cent of Max Life. The shares were subsequently acquired back in tranches at higher prices.

The 2020 arrangement initially proposed the acquisition of a 29.002 per cent stake in Max Life by Axis Bank. Following regulatory discussions, the structure was modified, with Axis entities eventually acquiring stakes in Max Life in March and April 2021.

Alleged ₹3,911 crore shareholder impact

Sebi's original show-cause notice alleged that the arrangements were structured to provide benefits to Axis entities beyond permissible commissions.

According to the allegations, the transactions resulted in an estimated ₹3,911.95 crore loss to Max Financial shareholders, with a corresponding benefit accruing to Axis Group entities.

However, the regulator's final order makes clear that these were allegations contained in the show-cause notice and were not ultimately established during the proceedings.

The conclusion marks an important distinction between allegations raised during regulatory investigation and findings ultimately supported by evidence.

Disclosure allegations could not be sustained

One of the central issues before Sebi was whether Max Financial had made adequate and timely disclosures about the transactions.

Sebi Whole Time Member Amarjeet Singh observed that disclosure standards for listed companies had evolved significantly over the years.

The regulator acknowledged that certain disclosures made by Max Financial could have been more comprehensive and that a more cautious approach might have been preferable.

However, Sebi said the company's conduct had to be assessed against the specific legal and regulatory requirements applicable at the time the transactions occurred.

In the absence of sufficient material establishing violations of the provisions cited in the show-cause notice, the disclosure-related charges could not be sustained.

Fraudulent scheme allegation rejected

Sebi also examined whether Max Financial, Max Life and Axis entities had deliberately structured the transactions to transfer benefits to Axis at the expense of Max Financial shareholders.

The regulator said active concealment of material information was not established.

It also found no evidence of manipulation of the company's share price or trading volumes, creation of an artificial market or other conduct that compromised market integrity.

Consequently, the allegation that Max Financial, Max Life, Axis Bank, Axis Capital and Axis Securities had collectively devised a fraudulent scheme to defraud Max Financial shareholders was not established.

Charges against senior executives also fall away

The proceedings extended to individuals who were responsible for Max Financial during different periods.

Sebi said that once the underlying allegations of disclosure violations and fraud against Max Financial were not established, the related charges against the company's key managerial personnel could also not be sustained.

The regulator additionally considered the individual roles and responsibilities of the persons named in the proceedings.

The final order consequently disposes of proceedings against seven individuals, including Analjit Singh.

13 independent and non-executive directors seek settlement

The original show-cause notice covered 25 entities.

Of these, 13 entities who served as non-executive or independent directors of Max Financial have filed settlement applications with Sebi.

Those applications are currently under process.

Under Sebi's settlement framework, filing a settlement application does not automatically terminate regulatory proceedings. Instead, the final order is kept in abeyance until the settlement application is decided.

Accordingly, Sebi has kept proceedings against these 13 entities in abeyance while issuing the final order for the remaining parties.

What the Sebi order means

The order closes a significant regulatory chapter surrounding historical transactions between Max and Axis entities.

For investors, the key takeaway is that Sebi did not establish the alleged ₹3,911.95 crore shareholder loss, fraudulent scheme or the specific disclosure violations cited in the proceedings.

The decision also highlights the importance of assessing historical corporate transactions against the regulatory framework that was actually applicable when those transactions took place.

At the same time, the regulator's observations regarding the adequacy of disclosures underline the increasing importance of transparency and detailed communication by listed companies, particularly when transactions involve related parties, strategic investors or substantial changes in ownership.

Focus shifts to remaining settlement proceedings

While Sebi has disposed of the proceedings against the entities and individuals covered by its final order, the matter is not entirely closed for all parties.

The settlement applications submitted by 13 former non-executive and independent directors remain under consideration.

The outcome of those applications will determine the next regulatory steps concerning those parties.